FingerprintDive into the research topics of 'Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis'. Together they form a unique fingerprint.
- Sort by
Paul O'Connor, David Miller, Katherine Riester, Minhua Yang, Michael Panzara, Catherine Dalton, Katherine Miszkiel, Omar Khan, George Rice, William Sheremata, G. J. Barker, D. G. MacManus, C. Webb, C. Middleditch, S. Lewis, T. Pepple, E. Riddle, C. Coombs, M. Agius, D. Richman
Research output: Contribution to journal › Article › peer-review